Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Transcat (TRNS) Cash & Equivalents (2019 - 2025)

Transcat's Cash & Equivalents history spans 11 years, with the latest figure at $3.5 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 25.19% year-over-year to $3.5 million; the TTM value through Dec 2025 reached $3.5 million, down 25.19%, while the annual FY2025 figure was $1.5 million, 92.28% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $3.5 million at Transcat, down from $5.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $35.2 million in Q4 2023 and bottomed at $254000.0 in Q2 2021.
  • The 5-year median for Cash & Equivalents is $2.0 million (2023), against an average of $6.7 million.
  • The largest annual shift saw Cash & Equivalents skyrocketed 2109.98% in 2023 before it tumbled 92.28% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $2.8 million in 2021, then tumbled by 42.68% to $1.6 million in 2022, then surged by 2109.98% to $35.2 million in 2023, then crashed by 86.82% to $4.6 million in 2024, then dropped by 25.19% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for TRNS's Cash & Equivalents are $3.5 million (Q4 2025), $5.1 million (Q3 2025), and $1.9 million (Q2 2025).